Current Advancements in Aβ Luminescent Probes and Inhibitors of Aβ Aggregation

Author(s): Dik-Lung Ma, Daniel Shiu-Hin Chan, Victor Pui-Yan Ma, Ka-Ho Leung, Hai-Jing Zhong, Chung-Hang Leung

Journal Name: Current Alzheimer Research

Volume 9 , Issue 7 , 2012

Become EABM
Become Reviewer
Call for Editor


Alzheimer’s disease (AD) is a neurodegenerative disorder that severely jeopardizes the health of aging populations all over the world. According to the amyloid cascade hypothesis, the pathological progression of AD is associated with the formation of amyloid plaques in the brain, resulting from the aggregation of amyloid-β (Aβ) peptides. Over the past few years, vast efforts have been dedicated to the development of amyloid probes and inhibitors for the diagnosis and effective treatment of AD. We review here recent advancements in luminescent probes for the detection of Aβ peptide and fibrils, and the current development of small molecule inhibitors of Aβ aggregation. We also highlight the key features in each specific example, as well as review new ideas and strategies that are crucial for researchers in this field.

Keywords: Aggregation inhibitor, Alzheimer’s disease, beta-amyloid, luminescent probe, therapeutics agents, cholinergic neurons, trauma, amyloid cascade.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 02 August, 2012
Page: [830 - 843]
Pages: 14
DOI: 10.2174/156720512802455377
Price: $65

Article Metrics

PDF: 14